General Studies Clause Samples

The General Studies clause outlines the requirements and expectations for students regarding non-specialized, broad-based coursework within an academic program. Typically, this clause specifies the number and types of general education credits students must complete, such as courses in humanities, sciences, mathematics, or social sciences, regardless of their major. Its core function is to ensure that all students receive a well-rounded education, promoting critical thinking and foundational knowledge beyond their chosen field of study.
General Studies. The General Studies curriculum has two strands  Self and Relationships  Daily Living These have been developed to meet the specific and special needs of the students at Port ▇▇▇▇▇▇▇ Specialist School. The strands incorporate the Key Learning Areas of Health, SOSE, Science and Technology, which are delivered within the framework of the Visual and Performing Arts.
View SourceView Similar (3)
General Studies. This document represents a transfer credit articulation agreement between St. Joseph’s College, NY, with campuses in Brooklyn and Patchogue, LI, and American Academy ▇▇▇▇▇▇▇▇▇▇ Institute, NY, for transfer students pursuing a Bachelor of Science degree in General Studies. This will serve as a guiding document for use by students, faculty and administrators of both institutions in clarifying the relationship between the schools and in confirming the way course credits transfer from American Academy ▇▇▇▇▇▇▇▇▇▇ Institute (AAMI) to St. Joseph’s College, NY (SJC). The attached Transfer Articulation Course Equivalencies documents are the result of dialogue between the St. Joseph’s College and AAMI Academic Deans and Department Chairpersons. Each course equivalent has been reviewed by both parties for content and transferability. The agreement may be modified, including adding or deleting course equivalencies, upon agreement of both parties. American Academy ▇▇▇▇▇▇▇▇▇▇ Institute A.O.S. in Funeral Service graduates are eligible to receive up to 64 semester hours of transfer credits when transferring to St. Joseph’s College, NY. Credit will only be awarded for courses completed with a grade of C or better. The overall grade point average must meet current St. Joseph’s College admissions requirements as stated in the SJC Catalogue, as well as program-specific requirements. The attached articulation agreement serves as a guideline for the maximum number of transfer credits from AAMI to St. Joseph’s. Students transferring to St. Joseph’s College from AAMI with the maximum number of credits will be given the opportunity to complete the requirements for a Bachelor of Science within four additional semesters of full-time study. SJC liberal arts/core requirements, distribution requirements, and course equivalencies for transfer credit purposes are contained within this document.
View SourceView Similar (2)
General Studies. The liberal arts component of a student’s program shall be selected according to the requirements of each state for the specific colleges to which students will transfer, taking into consideration the NASM guidelines and recommendations for general studies listed under the standards for the various baccalaureate degrees in music. VIII. B. Common Body of Knowledge and Skills 1. Performance. Students must acquire: a. Technical skills requisite for artistic self-expression in at least one major performance area at a level appropriate for the particular music concentration. b. An overview understanding of the repertory in their major performance area and the ability to perform from a cross-section of that repertory. c. The ability to read at sight with fluency demonstrating both general musicianship and, in the major performance area, a level of skill relevant to professional standards appropriate for the particular music concentration. d. Knowledge and skills sufficient to work as a leader and in collaboration on matters of musical interpretation. Rehearsal and conducting skills are required as appropriate to the particular music concentration. e. Keyboard competency. f. Growth in artistry, technical skills, collaborative competence and knowledge of repertory through regular ensemble experiences. Ensembles should be varied both in size and nature. Normally, performance study and ensemble experience continue throughout the baccalaureate program.
View Source
General Studies. Courses in this category are designed to meet individual student goals for personal improvement and self-understanding. Course credit is non- transferable and does not count toward associate degrees.
View Source
General Studies. The liberal arts component of a student’s program shall be selected according to the requirements of each state for the specific colleges to which students will transfer, taking into consideration the NASM guidelines and recommendations for general studies listed under the standards for the various baccalaureate degrees in music. VIII. B. Common Body of Knowledge and Skills 1. Performance. Students must acquire: a. Technical skills requisite for artistic self-expression in at least one major performance area at a level appropriate for the particular music concentration. b. An overview understanding of the repertory in their major performance area and the ability to perform from a cross-section of that repertory. c. The ability to read at sight with fluency demonstrating both general musicianship and, in the major performance area, a level of skill relevant to professional standards appropriate for the particular music concentration. d. Knowledge and skills sufficient to work as a leader and in collaboration on matters of musical interpretation. Rehearsal and conducting skills are required as appropriate to the particular music concentration.
View Source
General Studies. General studies courses that fulfill specific degree, general education or pre-requisites requirements. WTCS TECHNICAL COURSE UW-P EQUIVALENT COURSE
View Source
General Studies. To comply with this agreement, students must complete the associate degree with the major listed above and include the specific courses listed below. Credited courses completed as part of the A.A. or A.S. that do not apply to the general education at RCC or the UCO major transfer to UCO as electives. General Education requirements University Core completed with A.A or A.S. Courses taken at RCC and applied to the General Studies Program Requirements will be applied to the UCO General Studies Major Requirements or electives. Total at Redlands Community College 60-64 To be taken at the University of Central Oklahoma… 60-64 AESS 4851 Capstone in General Studies Select at least 36 hours from the following course subjects (prefix) with no more than 18 hours from any one area. Chosen from College of Business: ACCT, BADM, BCOM, ECON, ENTR, FIN, IB, ▇▇▇▇, ▇▇, MGMT, MLSC, MRKT Chosen from College of Education: AESS, CEPS, CTWD, ECED, ELED, FACS, FMCD, FMKT, HLTH, IME, KINS, NTRN, ORGL, PHED, PSY, PTE, READ, REC, SFTY, SLP, SPED, TESL Chosen from College of Fine Arts and Design: ACM, ART, DANC, DES, MPER, MUED, MUS, THRT
View Source

Related to General Studies

  • Clinical Studies The animal and other preclinical studies and clinical trials conducted by the Company or on behalf of the Company were, and, if still pending are, to the Company’s knowledge, being conducted in all material respects in compliance with all Applicable Laws and in accordance with experimental protocols, procedures and controls generally used by qualified experts in the preclinical study and clinical trials of new drugs and biologics as applied to comparable products to those being developed by the Company; the descriptions of the results of such preclinical studies and clinical trials contained in the Registration Statement and the Prospectus are accurate and complete in all material respects, and, except as set forth in the Registration Statement and the Prospectus, the Company has no knowledge of any other clinical trials or preclinical studies, the results of which reasonably call into question the clinical trial or preclinical study results described or referred to in the Registration Statement and the Prospectus when viewed in the context in which such results are described; and the Company has not received any written notices or correspondence from the FDA, the EMA, or any other domestic or foreign governmental agency requiring the termination, suspension or modification of any preclinical studies or clinical trials conducted by or on behalf of the Company that are described in the Registration Statement and the Prospectus or the results of which are referred to in the Registration Statement and the Prospectus.

  • Clinical Trials The studies, tests and preclinical and clinical trials conducted by or on behalf of, or sponsored by, the Company, or in which the Company has participated, that are described in the Registration Statement or the Prospectus, or the results of which are referred to in the Registration Statement or the Prospectus, were and, if still pending, are being conducted in all material respects in accordance with protocols, procedures and controls pursuant to, where applicable, accepted professional and scientific standards for products or product candidates comparable to those being developed by the Company and all applicable statutes, rules and regulations of the FDA, the EMA, Health Canada and other comparable regulatory agencies outside of the U.S. to which they are subject, including, without limitation, 21 C.F.R. Parts 50, 54, 56, 58, 312, and 812; the descriptions of the results of such studies, tests and trials contained in the Registration Statement or the Prospectus do not contain any misstatement of a material fact or omit a material fact necessary to make such statements not misleading; the Company has no knowledge of any studies, tests or trials not described in the Registration Statement or the Prospectus the results of which reasonably call into question in any material respect the results of the studies, tests and trials described in the Registration Statement or Prospectus; and the Company has not received any notices or other correspondence from the FDA, EMA, Health Canada or any other foreign, state or local governmental body exercising comparable authority or any Institutional Review Board or comparable authority requiring or threatening the termination, suspension or material modification of any studies, tests or preclinical or clinical trials conducted by or on behalf of, or sponsored by, the Company or in which the Company has participated, and, to the Company’s knowledge, there are no reasonable grounds for the same. Except as disclosed in the Registration Statement and the Prospectus, there has not been any violation of law or regulation by the Company in its respective product development efforts, submissions or reports to any regulatory authority that could reasonably be expected to require investigation, corrective action or enforcement action.

  • Trials The Ship shall run the following test and trials: (1) Harbour Acceptance Tests, including setting to work of the various equipment;

  • Studies The clinical, pre-clinical and other studies and tests conducted by or on behalf of or sponsored by the Company or its subsidiaries that are described or referred to in the Registration Statement, the Pricing Disclosure Package and the Prospectus were and, if still pending, are being conducted in accordance in all material respects with all statutes, laws, rules and regulations, as applicable (including, without limitation, those administered by the FDA or by any foreign, federal, state or local governmental or regulatory authority performing functions similar to those performed by the FDA). The descriptions of the results of such studies and tests that are described or referred to in the Registration Statement, the Pricing Disclosure Package and the Prospectus are accurate and complete in all material respects and fairly present the published data derived from such studies and tests, and each of the Company and its subsidiaries has no knowledge of other studies or tests the results of which are materially inconsistent with or otherwise call into question the results described or referred to in the Registration Statement, the Pricing Disclosure Package and the Prospectus. Except as described in the Registration Statement, the Pricing Disclosure Package and the Prospectus, neither the Company nor its subsidiaries has received any notices or other correspondence from the FDA or any other foreign, federal, state or local governmental or regulatory authority performing functions similar to those performed by the FDA with respect to any ongoing clinical or pre-clinical studies or tests requiring the termination or suspension of such studies or tests. For the avoidance of doubt, the Company makes no representation or warranty that the results of any studies, tests or preclinical or clinical trials conducted by or on behalf of the Company will be sufficient to obtain governmental approval from the FDA or any foreign, state or local governmental body exercising comparable authority.

  • Clinical 1.1 Provides comprehensive evidence based nursing care and individual case management to a specific group of patients/clients including assessment, intervention and evaluation. 1.2 Undertakes clinical shifts at the direction of senior staff and the Nursing Director including participation on the on-call/after-hours/weekend roster if required. 1.3 Responsible and accountable for patient safety and quality of care through planning, coordinating, performing, facilitating, and evaluating the delivery of patient care relating to a particular group of patients, clients or staff in the practice setting. 1.4 Monitors, reviews and reports upon the standard of nursing practice to ensure that colleagues are working within the scope of nursing practice, following appropriate clinical pathways, policies, procedures and adopting a risk management approach in patient care delivery. 1.5 Participates in ▇▇▇▇ rounds/case conferences as appropriate. 1.6 Educates patients/carers in post discharge management and organises discharge summaries/referrals to other services, as appropriate. 1.7 Supports and liaises with patients, carers, colleagues, medical, nursing, allied health, support staff, external agencies and the private sector to provide coordinated multidisciplinary care. 1.8 Completes clinical documentation and undertakes other administrative/management tasks as required. 1.9 Participates in departmental and other meetings as required to meet organisational and service objectives. 1.10 Develops and seeks to implement change utilising expert clinical knowledge through research and evidence based best practice. 1.11 Monitors and maintains availability of consumable stock. 1.12 Complies with and demonstrates a positive commitment to Regulations, Acts and Policies relevant to nursing including the Code of Ethics for Nurses in Australia, the Code of Conduct for Nurses in Australia, the National Competency Standards for the Registered Nurse and the Poisons Act 2014 and Medicines and Poisons Regulations 2016. 1.13 Promotes and participates in team building and decision making. 1.14 Responsible for the clinical supervision of nurses at Level 1 and/or Enrolled Nurses/ Assistants in Nursing under their supervision.